₹ 2,518.00
-19.90 (-0.78%)
M
Mankind Pharma
₹ 2,518.00
Mankind Pharma Share Price Today
Mankind Pharma (MANKIND) share price is trading at ₹2,518.00 on the NSE as of November 5, 2026 at 03:56 PM, down by 0.78% from its previous close of ₹2,537.90. In todays trading session MANKIND reached a high of 2,561.20 and low of 2,495.00. The average traded price for today is 2,515.98. The 50 DMA stands at 2,392.02 and 200 DMA is at 2,318.41. Looking at intraday trend, the stock is moving sideways.
Stock Overview
- Symbol : MANKIND
- Open : ₹2,560.00
- Previous Close : ₹2,537.90
- Day's Range : ₹2,495.00 – ₹2,561.20
- 52-Week Range : ₹1,909.70 – ₹2,642.00
Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.
MANKIND Stock Performance
Markets Today
High
2,561.20
Low
2,495.00
Open at
2,560.00
Prev Close
2,537.90
Volumes
3,77,293
Avg Price
2,515.98
Lower Circuit
2,266.20
Upper Circuit
2,769.80
Last Traded Details
Quantity
3
Time
15:56:02
Price Movement
Historical Performance
3 M High
2,561.20
3 M Low
2,196.10
1 Yr High
2,642.00
1 Yr Low
1,909.70
3 Yr High
3,054.80
3 Yr Low
1,733.00
5 Yr High
3,054.80
5 Yr Low
1,242.00
1-Year Performance
MANKIND Pros and Cons
Revenue grows from ₹3,697 Cr to ₹4,031 Cr from Q2 FY26 to Q1 FY27 — top line recovers after two quarters of decline
EBITDA rises from ₹924 Cr to ₹1,060 Cr from Q2 FY26 to Q1 FY27 — margin improves from 25.0% to 26.3%
Net debt falls from ₹4,791 Cr to ₹3,377 Cr from Q2 FY26 to Q1 FY27 — leverage eases from 1.4x to 0.9x
Exports revenue grows from ₹513 Cr to ₹605 Cr from Q2 FY26 to Q1 FY27 — mix rises from 7% to 15%
Adj. ROCE improves from 41% to 43% from Q2 FY26 to Q1 FY27 — capital returns stay strong
BSV-adjusted working capital days rise from 46 to 52 days from Q2 FY26 to Q1 FY27 — cash conversion is stretched
CAPEX rises from ₹127 Cr to ₹198 Cr from Q2 FY26 to Q1 FY27 — investment remains elevated
Consumer Healthcare EBITDA margin eases from 21.4% in Q4 FY26 to 18.6% in Q1 FY27 — segment profitability is volatile
Domestic Business revenue stays nearly flat from ₹3,184 Cr in Q2 FY26 to ₹3,180 Cr in Q1 FY27 — core growth has not recovered
MANKIND Analyst Rating
Buy
Analysts have suggested that investors can
Buy this Stock
- By Refinitiv from 19 analysts
Buy
63.16%
Hold
21.05%
Sell
15.79%
Get forecast for Price, ROA & ROE based on analyst ratings.
MANKIND Share Price History
MANKIND Fundamentals
Company Valuation
Market Cap (₹ Cr.)
1,04,005
PE Ratio
46.20
PB Ratio
5.95
Dividend Yield
0.04%
ROE
11.70%
ROCE
13.78%
Book Value (₹)
425.67
Face Value (₹)
1.00
Analyse MANKIND with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 72.67% | 72.66% | 72.66% | 72.63% | 72.62% |
| Domestic Institutional Investors (DII) | 11.92% | 13.25% | 14.46% | 15.39% | 15.56% |
| Foreign Institutional Investors (FII) | 12.84% | 11.34% | 10.24% | 9.45% | 9.37% |
| Public Investors | 1.36% | 1.52% | 1.39% | 1.29% | 1.26% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
Mankind Pharma Return Calculator
Note: Past profits do not guarantee future returns.
MANKIND Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
MANKIND Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for MANKIND
Margin on MANKIND
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
MANKIND Financials Summary
In Crores
MANKIND Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
The above dates are ex-dates.
Check MANKIND latest Company Filings, Investor Presentation & Conference Call details.
MANKIND Revenue Growth
All values are in Crores
Revenue
Profit
Loss
MANKIND Options Snapshot
MANKIND Futures Snapshot
Use from 12+ Pre-built Strategies or Build Your Own to trade MANKIND FnO contracts.
MANKIND Similar Stocks
FAQs on MANKIND
What is the share price of Mankind Pharma?
What is the 52W high and 52W low of Mankind Pharma?
What is the return on Mankind Pharma share?
- Past 1 year: 6.27%
- Past 3 years: 41.85%
- Past 5 years: 77.04%
What is the PE and PB Ratio of Mankind Pharma?
What is the EPS of Mankind Pharma?
What is the shareholding pattern of Mankind Pharma?
- DIIs - 15.56%
- FII - 9.37%
- Promoters - 72.62%
- Public Investors 1.26%
- Goverenment - 0.00%
How to buy Mankind Pharma shares online?
How to buy Mankind Pharma shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Mankind Pharma share
- Tap on “Buy”
Option Chain